BioAge Labs, Inc. (BIOA)
8.06
-0.03
(-0.37%)
USD |
NASDAQ |
Sep 18, 16:00
8.06
0.00 (0.00%)
After-Hours: 20:00
BioAge Labs Price to Book Value : 0.9841 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.9841 |
| September 17, 2026 | 0.9878 |
| September 16, 2026 | 0.9463 |
| September 15, 2026 | 0.9988 |
| September 14, 2026 | 1.035 |
| September 11, 2026 | 1.037 |
| September 10, 2026 | 1.056 |
| September 09, 2026 | 1.120 |
| September 08, 2026 | 1.147 |
| September 04, 2026 | 1.171 |
| September 03, 2026 | 1.16 |
| September 02, 2026 | 1.188 |
| September 01, 2026 | 1.162 |
| August 31, 2026 | 1.16 |
| August 28, 2026 | 1.178 |
| August 27, 2026 | 1.231 |
| August 26, 2026 | 1.202 |
| August 25, 2026 | 1.234 |
| August 24, 2026 | 1.145 |
| August 21, 2026 | 1.158 |
| August 20, 2026 | 1.183 |
| August 19, 2026 | 1.313 |
| August 18, 2026 | 1.277 |
| August 17, 2026 | 1.270 |
| August 14, 2026 | 1.294 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.274 |
| August 12, 2026 | 1.280 |
| August 11, 2026 | 1.303 |
| August 10, 2026 | 1.398 |
| August 07, 2026 | 1.431 |
| August 06, 2026 | 1.376 |
| August 05, 2026 | 1.341 |
| August 04, 2026 | 1.368 |
| August 03, 2026 | 1.316 |
| July 31, 2026 | 1.104 |
| July 30, 2026 | 3.034 |
| July 29, 2026 | 2.709 |
| July 28, 2026 | 2.676 |
| July 27, 2026 | 2.550 |
| July 24, 2026 | 2.658 |
| July 23, 2026 | 2.674 |
| July 22, 2026 | 2.679 |
| July 21, 2026 | 2.766 |
| July 20, 2026 | 2.725 |
| July 17, 2026 | 2.785 |
| July 16, 2026 | 2.706 |
| July 15, 2026 | 2.772 |
| July 14, 2026 | 2.781 |
| July 13, 2026 | 2.66 |
| July 10, 2026 | 2.972 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.04 |
| Pfizer Inc. | 1.850 |
| Oramed Pharmaceuticals, Inc. | 0.6168 |
| Liquidia Corp. | 30.54 |
| Neumora Therapeutics, Inc. | 3.064 |
Price to Book Value Related Metrics
| PS Ratio | 30.99 |
| PEG Ratio | -0.5004 |
| Price | 8.06 |
| Earnings Yield | -29.61% |
| Market Cap | 368.96M |
| PEGY Ratio | -0.5004 |